Debt Instrument, Floor Interest Rate

No definition available.

Name:	oyst_DebtInstrumentFloorInterestRate
Namespace Prefix:	oyst_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Debt Instrument, Period Payment, Net Recurring Revenue, Tier One

+ References

No definition available.

+ Details

Name:	oyst_DebtInstrumentPeriodPaymentNetRecurringRevenueTierOne
Namespace Prefix:	oyst_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Debt Instrument, Periodic Payment, Interest, Percent Of Revenue, First Tier

+ References

No definition available.

+ Details

Name:	oyst_DebtInstrumentPeriodicPaymentInterestPercentOfRevenueFirstTier
Namespace Prefix:	oyst_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

Debt Instrument, Periodic Payment, Interest, Percent Of Revenue, Second Tier

+ References

No definition available.

+ Details

Name:	oyst_DebtInstrumentPeriodicPaymentInterestPercentOfRevenueSecondTier
Namespace Prefix:	oyst_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

Debt Instrument, Periodic Payment, Net Recurring Revenue, Tier Two

+ References

No definition available.

+ Details

Name:	oyst_DebtInstrumentPeriodicPaymentNetRecurringRevenueTierTwo
Namespace Prefix:	oyst_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Debt instrument, Restrictive Covenant, Minimum Liquidity After FDA Approval

+ References

No definition available.

+ Details

Name:	oyst_DebtInstrumentRestrictiveCovenantMinimumLiquidityAfterFDAApproval
Namespace Prefix:	oyst_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Long-Term Debt, Accrued Revenue Sharing Fee

+ References

No definition available.

+ Details

Name:	oyst_LongTermDebtAccruedRevenueSharingFee
Namespace Prefix:	oyst_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Amount of amortization expense attributable to debt issuance costs.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(8))
-URI http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1F
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399

+ Details

Name:	us-gaap_AmortizationOfFinancingCosts
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Percentage points added to the reference rate to compute the variable rate on the debt instrument.

+ References

No definition available.

+ Details

Name:	us-gaap_DebtInstrumentBasisSpreadOnVariableRate1
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 6
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22(a)(1))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

+ Details

Name:	us-gaap_DebtInstrumentInterestRateEffectivePercentage
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_DebtInstrumentLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of commitment fees for the unused borrowing capacity under the long-term financing arrangement that is available to the entity.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22(b))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

+ Details

Name:	us-gaap_DebtInstrumentUnusedBorrowingCapacityFee
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Amount of the cost of borrowed funds accounted for as interest expense.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (210.5-03(11))
-URI http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04.9)
-URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

+ Details

Name:	us-gaap_InterestExpense
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Details

Name:	us-gaap_DebtInstrumentAxis=us-gaap_LineOfCreditMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_DebtInstrumentAxis=oyst_OrbiMedCreditFacilityMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_RangeAxis=srt_MaximumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_RangeAxis=srt_MinimumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Long-term Debt - Narrative (Details) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended		12 Months Ended
	Aug. 05, 2021	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Debt Instrument [Line Items]
Interest expense		$ (3,495)	$ (1,124)	$ (9,717)	$ (1,124)
Line of Credit
Debt Instrument [Line Items]
Amortization of debt issuance costs		1,000		3,100
Revolving Credit Facility \| OrbiMed Credit Facility
Debt Instrument [Line Items]
Interest rate floor	0.40%
Quarterly revenue interest payments, percentage of net recurring revenue up to specified amount	3.00%
Quarterly revenue interest payments, percentage of net recurring revenue over specified amount to aggregate cap	1.00%
Accrued revenue sharing fee		$ 200		200		$ 200
Undrawn loan commitment fees				$ 300		$ 600
Minimum liquidity covenant after FDA approval	$ 5,000
Revolving Credit Facility \| OrbiMed Credit Facility \| Maximum
Debt Instrument [Line Items]
Quarterly payments (up to)	300,000
Net recurring revenue from annual sales and licenses over specified amount to aggregate cap	500,000
Revolving Credit Facility \| OrbiMed Credit Facility \| Minimum
Debt Instrument [Line Items]
Net recurring revenue from annual sales and licenses over specified amount to aggregate cap	$ 300,000
Effective interest rate on credit facility		16.04%		16.04%
Revolving Credit Facility \| OrbiMed Credit Facility \| Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate
Debt Instrument [Line Items]
Interest rate (as a percentage)	8.10%